Frailty and Cancer: Current Perspectives on Assessment and Monitoring

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Matsuda T, Saika K. Age-specific cancer incidence rate in the world. Jpn J Clin Oncol. 2020;50(5):626–627. doi:10.1093/jjco/hyaa057
   PubMed Web of Science ®Google Scholar
• National cancer institute Surveillance, Epidemiology, and End Results Program (SEER). Available from: https://seer.cancer.gov/. Accessed November 6, 2022.
   Google Scholar
• Doody P, Lord JM, Greig CA, Whittaker AC. Frailty: pathophysiology, theoretical and operational definition(s), impact, prevalence, management and prevention, in an increasingly economically developed and ageing world. Gerontology. 2022. doi:10.1159/000528561
   PubMed Web of Science ®Google Scholar
• Ribeiro AR, Howlett SE, Fernandes A. Frailty-A promising concept to evaluate disease vulnerability. Mech Ageing Dev. 2020;187:111217.
   PubMed Web of Science ®Google Scholar
• Dent E, Martin FC, Bergman H, Woo J, Romero-Ortuno R, Walston JD. Management of frailty: opportunities, challenges, and future directions. Lancet. 2019;394(10206):1376–1386.
   PubMed Web of Science ®Google Scholar
• Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–762.
   PubMed Web of Science ®Google Scholar
• Handforth C, Clegg A, Young C, et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol. 2015;26(6):1091–1101.
   PubMed Web of Science ®Google Scholar
• Ethun CG, Bilen MA, Jani AB, Maithel SK, Ogan K, Master VA. Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology. CA Cancer J Clin. 2017;67(5):362–377.
   PubMed Web of Science ®Google Scholar
• Jespersen E, Winther SB, Minet LR, Moller S, Pfeiffer P. Frailty screening for predicting rapid functional decline, rapid progressive disease, and shorter overall survival in older patients with gastrointestinal cancer receiving palliative chemotherapy - a prospective, clinical study. J Geriatr Oncol. 2021;12(4):578–584. doi:10.1016/j.jgo.2020.10.007
   PubMed Web of Science ®Google Scholar
• Narasimhulu DM, McGree ME, Weaver AL, et al. Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer. Gynecol Oncol. 2020;158(3):646–652. doi:10.1016/j.ygyno.2020.05.046
   PubMed Web of Science ®Google Scholar
• Shaw JF, Budiansky D, Sharif F, McIsaac DI. The association of frailty with outcomes after cancer surgery: a systematic review and metaanalysis. Ann Surg Oncol. 2022;29(8):4690–4704. doi:10.1245/s10434-021-11321-2
   PubMed Web of Science ®Google Scholar
• Overcash J, Cope DG, Van Cleave JH. Frailty in older adults: assessment, support, and treatment implications in patients with cancer. Clin J Oncol Nurs. 2018;22(6):8–18. doi:10.1188/18.CJON.S2.8-18
   PubMed Web of Science ®Google Scholar
• Extermann M. Integrating a geriatric evaluation in the clinical setting. Semin Radiat Oncol. 2012;22(4):272–276. doi:10.1016/j.semradonc.2012.05.003
   PubMed Web of Science ®Google Scholar
• Balducci L, Extermann M. Management of the frail person with advanced cancer. Crit Rev Oncol Hematol. 2000;33(2):143–148. doi:10.1016/S1040-8428(99)00063-3
   PubMed Web of Science ®Google Scholar
• Magnuson A, Allore H, Cohen HJ, et al. Geriatric assessment with management in cancer care: current evidence and potential mechanisms for future research. J Geriatr Oncol. 2016;7(4):242–248. doi:10.1016/j.jgo.2016.02.007
   PubMed Web of Science ®Google Scholar
• International Society of Geriatrie Oncology (SIOG). Comprehensive geriatric assessment. Available from: https://siog.org/resources/resources-siog/comprehensive-geriatric-assessment/. Accessed November 6, 2022.
   Google Scholar
• Wildiers H, Heeren P, Puts M, et al. International society of geriatric oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32(24):2595–2603. doi:10.1200/JCO.2013.54.8347
   PubMed Web of Science ®Google Scholar
• Mohile SG, Dale W, Somerfield MR, et al. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol. 2018;36(22):2326–2347. doi:10.1200/JCO.2018.78.8687
   PubMed Web of Science ®Google Scholar
• Goede V, Neuendorff NR, Schulz RJ, Hormigo AI, Martinez-Peromingo FJ, Cordoba R. Frailty assessment in the care of older people with haematological malignancies. Lancet Healthy Longev. 2021;2(11):e736–e745.
   PubMedGoogle Scholar
• Kenis C, Decoster L, Bastin J, et al. Functional decline in older patients with cancer receiving chemotherapy: a multicenter prospective study. J Geriatr Oncol. 2017;8(3):196–205.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network (NCCN). Older adult oncology. Available from: https://www.nccn.org/guidelines/guidelines-detail?category=4&id=1452. Accessed November 6, 2022.
   Google Scholar
• Brivio P, Paladini MS, Racagni G, Riva MA, Calabrese F, Molteni R. From healthy aging to frailty: in search of the underlying mechanisms. Curr Med Chem. 2019;26(20):3685–3701.
   PubMed Web of Science ®Google Scholar
• Weiss CO. Frailty and chronic diseases in older adults. Clin Geriatr Med. 2011;27(1):39–52.
   PubMed Web of Science ®Google Scholar
• Zampino M, Ferrucci L, Semba RD. Biomarkers in the path from cellular senescence to frailty. Exp Gerontol. 2020;129:110750.
   PubMed Web of Science ®Google Scholar
• Boccardi V, Mecocci P. The importance of cellular senescence in frailty and cardiovascular diseases. Adv Exp Med Biol. 2020;1216:79–86.
   PubMed Web of Science ®Google Scholar
• Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15(9):505–522.
   PubMed Web of Science ®Google Scholar
• Monfardini S, Basso U. Oncological causes of frailty in older cancer patients. Eur J Cancer. 2007;43(8):1230–1231.
   PubMed Web of Science ®Google Scholar
• Zhang D, Mobley EM, Manini TM, et al. Frailty and risk of mortality in older cancer survivors and adults without a cancer history: evidence from the National Health and Nutrition Examination Survey, 1999–2014. Cancer. 2022;128(15):2978–2987.
   PubMed Web of Science ®Google Scholar
• Belloni G, Cesari M. Frailty and intrinsic capacity: two distinct but related constructs. Front Med. 2019;6:133.
   Web of Science ®Google Scholar
• Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol a Biol Sci Med Sci. 2001;56(3):M146–M156.
   PubMed Web of Science ®Google Scholar
• Mitnitski AB, Mogilner AJ, MacKnight C, Rockwood K. The mortality rate as a function of accumulated deficits in a frailty index. Mech Ageing Dev. 2002;123(11):1457–1460.
   PubMed Web of Science ®Google Scholar
• Martin FC, O’Halloran AM. Tools for assessing frailty in older people: general concepts. Adv Exp Med Biol. 2020;1216:9–19.
   PubMed Web of Science ®Google Scholar
• McCusker J, Bellavance F, Cardin S, Trepanier S. Screening for geriatric problems in the emergency department: reliability and validity. Identification of Seniors at Risk (ISAR) Steering Committee. Acad Emerg Med. 1998;5(9):883–893.
   PubMed Web of Science ®Google Scholar
• Steverink N, Slaets JP, Schuurmans H, van Lis M. Measuring frailty: developing and testing the GFI (Groningen Frailty Indicator). Gerontologist. 2001;41(1):236.
   Google Scholar
• Saliba D, Elliott M, Rubenstein LZ, et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49(12):1691–1699.
   PubMed Web of Science ®Google Scholar
• Hustey FM, Mion LC, Connor JT, Emerman CL, Campbell J, Palmer RM. A brief risk stratification tool to predict functional decline in older adults discharged from emergency departments. J Am Geriatr Soc. 2007;55(8):1269–1274.
   PubMed Web of Science ®Google Scholar
• Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–495.
   PubMed Web of Science ®Google Scholar
• Church S, Rogers E, Rockwood K, Theou O. A scoping review of the Clinical Frailty Scale. BMC Geriatr. 2020;20(1):393.
   PubMed Web of Science ®Google Scholar
• Kastora S, Kounidas G, Perrott S, Carter B, Hewitt J, Myint PK. Clinical frailty scale as a point of care prognostic indicator of mortality in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2021;36:100896.
   PubMedGoogle Scholar
• Veronese N, Custodero C, Demurtas J, et al. Comprehensive geriatric assessment in older people: an umbrella review of health outcomes. Age Ageing. 2022;51:5.
   Web of Science ®Google Scholar
• Ellis G, Gardner M, Tsiachristas A, et al. Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev. 2017;9:CD006211.
   PubMedGoogle Scholar
• Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–186.
   PubMed Web of Science ®Google Scholar
• Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1970;10(1):20–30.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–148.
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. ”Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
   PubMed Web of Science ®Google Scholar
• Demurtas J, Ecarnot F, Cernesi S, Solari M, Munoz MA, Cella A. Comprehensive geriatric assessment in cardiovascular disease. Adv Exp Med Biol. 2020;1216:87–97.
   PubMed Web of Science ®Google Scholar
• Eamer G, Taheri A, Chen SS, et al. Comprehensive geriatric assessment for older people admitted to a surgical service. Cochrane Database Syst Rev. 2018;1:CD012485.
   PubMedGoogle Scholar
• Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–655.
   PubMed Web of Science ®Google Scholar
• Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, editor. Evaluation of Chemotherapeutic Agents. Columbia, Univ Press; 1949:196.
   Google Scholar
• Jolly TA, Deal AM, Nyrop KA, et al. Geriatric assessment-identified deficits in older cancer patients with normal performance status. Oncologist. 2015;20(4):379–385.
   PubMed Web of Science ®Google Scholar
• Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29(25):3457–3465.
   PubMed Web of Science ®Google Scholar
• Bellera CA, Rainfray M, Mathoulin-Pelissier S, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012;23(8):2166–2172.
   PubMed Web of Science ®Google Scholar
• Decoster L, Van Puyvelde K, Mohile S, et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol. 2015;26(2):288–300.
   PubMed Web of Science ®Google Scholar
• van Walree IC, Scheepers E, van Huis-Tanja L, et al. A systematic review on the association of the G8 with geriatric assessment, prognosis and course of treatment in older patients with cancer. J Geriatr Oncol. 2019;10(6):847–858.
   PubMed Web of Science ®Google Scholar
• van Walree IC, Vondeling AM, Vink GR, et al. Development of a self-reported version of the G8 screening tool. J Geriatr Oncol. 2019;10(6):926–930.
   PubMed Web of Science ®Google Scholar
• Garcia MV, Agar MR, Soo WK, To T, Phillips JL. Screening tools for identifying older adults with cancer who may benefit from a geriatric assessment: a systematic review. JAMA Oncol. 2021;7(4):616–627.
   PubMed Web of Science ®Google Scholar
• Hamaker ME, Jonker JM, de Rooij SE, Vos AG, Smorenburg CH, van Munster BC. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol. 2012;13(10):e437–e444.
   PubMed Web of Science ®Google Scholar
• Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012;118(13):3377–3386.
   PubMed Web of Science ®Google Scholar
• Hamaker M, Lund C, Te Molder M, et al. Geriatric assessment in the management of older patients with cancer - A systematic review (update). J Geriatr Oncol. 2022;13(6):761–777.
   PubMed Web of Science ®Google Scholar
• Puts M, Soo WK, Szumacher E, Decoster L. Methods for frailty screening and geriatric assessment in older adults with cancer. Curr Opin Support Palliat Care. 2021;15(1):16–22.
   PubMed Web of Science ®Google Scholar
• Mohile SG, Mohamed MR, Xu H, et al. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. Lancet. 2021;398(10314):1894–1904.
   PubMed Web of Science ®Google Scholar
• Li D, Sun CL, Kim H, et al. Geriatric Assessment-Driven Intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial. JAMA Oncol. 2021;7(11):e214158.
   PubMed Web of Science ®Google Scholar
• Soo WK, King MT, Pope A, Parente P, Darzins P, Davis ID. Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial. Lancet Healthy Longev. 2022;3(9):e617–e627.
   PubMedGoogle Scholar
• Lund CM, Vistisen KK, Olsen AP, et al. The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO). Br J Cancer. 2021;124(12):1949–1958.
   PubMed Web of Science ®Google Scholar
• Puts N, Alqurini N, Strohschein F, et al. Comprehensive geriatric assessment and management for Canadian elders with Cancer: the 5C study. J Clin Oncol. 2021;39(15_suppl):12011.
   Web of Science ®Google Scholar
• Orum M, Eriksen SV, Gregersen M, et al. The impact of a tailored follow-up intervention on comprehensive geriatric assessment in older patients with cancer - a randomised controlled trial. J Geriatr Oncol. 2021;12(1):41–48.
   PubMed Web of Science ®Google Scholar
• DuMontier C, Uno H, Hshieh T, et al. Randomized controlled trial of geriatric consultation versus standard care in older adults with hematologic malignancies. Haematologica. 2022;107(5):1172–1180.
   PubMed Web of Science ®Google Scholar
• Karnakis T, Gattas-Vernaglia IF, Saraiva MD, Gil-Junior LA, Kanaji AL, Jacob-Filho W. The geriatrician’s perspective on practical aspects of the multidisciplinary care of older adults with cancer. J Geriatr Oncol. 2016;7(5):341–345.
   PubMed Web of Science ®Google Scholar
• Goede V, Stauder R. Multidisciplinary care in the hematology clinic: implementation of geriatric oncology. J Geriatr Oncol. 2019;10(3):497–503.
   PubMed Web of Science ®Google Scholar
• Gilmore N, Kadambi S, Lei L, et al. Associations of inflammation with frailty in patients with breast cancer aged 50 and over receiving chemotherapy. J Geriatr Oncol. 2020;11(3):423–430.
   PubMed Web of Science ®Google Scholar
• Montroni I, Ugolini G, Saur NM, et al. Quality of life in older adults after major cancer surgery: the GOSAFE International Study. J Natl Cancer Inst. 2022;114(7):969–978.
   PubMedGoogle Scholar
• Huehnchen P, van Kampen A, Boehmerle W, Endres M. Cognitive impairment after cytotoxic chemotherapy. Neurooncol Pract. 2020;7(1):11–21.
   PubMed Web of Science ®Google Scholar
• Le Saux O, Falandry C, Gan HK, You B, Freyer G, Peron J. Changes in the use of end points in clinical trials for elderly cancer patients over time. Ann Oncol. 2017;28(10):2606–2611.
   PubMed Web of Science ®Google Scholar
• Nipp RD, Yao NA, Lowenstein LM, et al. Pragmatic study designs for older adults with cancer: report from the U13 conference. J Geriatr Oncol. 2016;7(4):234–241.
   PubMed Web of Science ®Google Scholar
• Ghignone F, Hernandez P, Mahmoud NN, Ugolini G. Functional recovery in senior adults undergoing surgery for colorectal cancer: assessment tools and strategies to preserve functional status. Eur J Surg Oncol. 2020;46(3):387–393.
   PubMed Web of Science ®Google Scholar
• Pergolotti M, Lyons KD, Williams GR. Moving beyond symptom management towards cancer rehabilitation for older adults: answering the 5W’s. J Geriatr Oncol. 2018;9(6):543–549.
   PubMed Web of Science ®Google Scholar
• Cruz AM, Monsalve L, Ladurner AM, Jaime LF, Wang D, Quiroga DA. Information and communication technologies for managing frailty: a systematic literature review. Aging Dis. 2021;12(3):914–933.
   PubMed Web of Science ®Google Scholar
• Vavasour G, Giggins OM, Doyle J, Kelly D. How wearable sensors have been utilised to evaluate frailty in older adults: a systematic review. J Neuroeng Rehabil. 2021;18(1):112.
   PubMed Web of Science ®Google Scholar
• Park C, Mishra R, Golledge J, Najafi B. Digital biomarkers of physical frailty and frailty phenotypes using sensor-based physical activity and machine learning. Sensors. 2021;21:16.
   Web of Science ®Google Scholar
• Zhou H, Park C, Shahbazi M, et al. Digital biomarkers of cognitive frailty: the value of detailed gait assessment beyond gait speed. Gerontology. 2022;68(2):224–233.
   PubMed Web of Science ®Google Scholar
• Zahiri M, Chen KM, Zhou H, et al. Using wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults - Toward an early diagnosis of CIPN. J Geriatr Oncol. 2019;10(6):960–967.
   PubMed Web of Science ®Google Scholar
• Nilanon T, Nocera LP, Martin AS, et al. Use of wearable activity tracker in patients with cancer undergoing chemotherapy: toward evaluating risk of unplanned health care encounters. JCO Clin Cancer Inform. 2020;4:839–853.
   PubMed Web of Science ®Google Scholar
• Banna GL, Cantale O, Haydock MM, et al. International survey on frailty assessment in patients with cancer. Oncologist. 2022;27(10):e796–e803.
   PubMed Web of Science ®Google Scholar
• Pearce J, Swinson D, Cairns D, et al. Frailty and treatment outcome in advanced gastro-oesophageal cancer: an exploratory analysis of the GO2 trial. J Geriatr Oncol. 2022;13(3):287–293.
   PubMed Web of Science ®Google Scholar
• Philip FA, Jagathnath Krishna KM, Bhargavan RV, Augustine P, Thomas S. Comparison of preoperative assessment tools in older patients undergoing cancer surgery: a prospective study. J Geriatr Oncol. 2022;13(4):420–425.
   PubMed Web of Science ®Google Scholar
• Stamatakos PV, Moschotzopoulos D, Glykas I, et al. Outcomes of radical cystectomy in pT4 bladder cancer frail patients: alpha high-volume single center study. J Frailty Sarcopenia Falls. 2022;7(3):147–150.
   PubMedGoogle Scholar
• Osatnik J, Matarrese A, Leone B, et al. Frailty and clinical outcomes in critically ill patients with cancer: a cohort study. J Geriatr Oncol. 2022;13:1156–1161.
   PubMed Web of Science ®Google Scholar
• Niemelainen S, Huhtala H, Jamsen E, et al. One-year functional outcomes of patients aged 80 years or more undergoing colonic cancer surgery: prospective, multicentre observational study. BJS Open. 2022;6(4):zrac094.
   PubMed Web of Science ®Google Scholar
• Mima K, Hayashi H, Nakagawa S, et al. Frailty is associated with poor prognosis after resection for pancreatic cancer. Int J Clin Oncol. 2021;26(10):1938–1946.
   PubMed Web of Science ®Google Scholar
• Chuang MH, Chen JY, Tsai WW, et al. Impact of comprehensive geriatric assessment on the risk of adverse events in the older patients receiving anti-cancer therapy: a systematic review and meta-analysis. Age Ageing. 2022;51:7.
   Web of Science ®Google Scholar
• Scheepers ERM, Vondeling AM, Thielen N, van der Griend R, Stauder R, Hamaker ME. Geriatric assessment in older patients with a hematologic malignancy: a systematic review. Haematologica. 2020;105(6):1484–1493.
   PubMed Web of Science ®Google Scholar
• Bruijnen CP, van Harten-Krouwel DG, Koldenhof JJ, Emmelot-Vonk MH, Witteveen PO. Predictive value of each geriatric assessment domain for older patients with cancer: a systematic review. J Geriatr Oncol. 2019;10(6):859–873.
   PubMed Web of Science ®Google Scholar
• Hamaker ME, Te Molder M, Thielen N, van Munster BC, Schiphorst AH, van Huis LH. The effect of a geriatric evaluation on treatment decisions and outcome for older cancer patients - A systematic review. J Geriatr Oncol. 2018;9(5):430–440.
   PubMed Web of Science ®Google Scholar
• Hamaker ME, Prins MC, Stauder R. The relevance of a geriatric assessment for elderly patients with a haematological malignancy--a systematic review. Leuk Res. 2014;38(3):275–283.
   PubMed Web of Science ®Google Scholar
• Puts MT, Santos B, Hardt J, et al. An update on a systematic review of the use of geriatric assessment for older adults in oncology. Ann Oncol. 2014;25(2):307–315.
   PubMed Web of Science ®Google Scholar
• Ramjaun A, Nassif MO, Krotneva S, Huang AR, Meguerditchian AN. Improved targeting of cancer care for older patients: a systematic review of the utility of comprehensive geriatric assessment. J Geriatr Oncol. 2013;4(3):271–281.
   PubMed Web of Science ®Google Scholar
• Puts MT, Hardt J, Monette J, Girre V, Springall E, Alibhai SM. Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst. 2012;104(15):1133–1163.
   PubMedGoogle Scholar
• Suto H, Inui Y, Okamura A. Validity of the cancer and aging research group predictive tool in older Japanese patients. Cancers. 2022;14:9.
   Web of Science ®Google Scholar
• Cavdar E, Iriagac Y, Karaboyun K, Avci O, Seber ES. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer. J Geriatr Oncol. 2022;13(6):821–827. doi:10.1016/j.jgo.2022.03.004
   PubMed Web of Science ®Google Scholar
• Mittal A, Rangaraju RR, Agarwal A, Chandragouda D, Batra S, Qureshi S. Estimating the risk of chemotherapy toxicity in Indian geriatric patient population and utility of chemotherapy risk assessment scale for high age patients (CRASH) score. South Asian J Cancer. 2021;10(3):161–166. doi:10.1055/s-0041-1729447
   PubMedGoogle Scholar
• Ostwal V, Ramaswamy A, Bhargava P, et al. Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study. BMJ Open. 2021;11(6):e047376. doi:10.1136/bmjopen-2020-047376
   PubMed Web of Science ®Google Scholar
• Alibhai SMH, Breunis H, Hansen AR, et al. Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen-receptor-targeted therapy for metastatic castration-resistant prostate cancer. Cancer. 2021;127(14):2587–2594. doi:10.1002/cncr.33523
   PubMed Web of Science ®Google Scholar
• Chan WL, Ma T, Cheung KL, et al. The predictive value of G8 and the Cancer and aging research group chemotherapy toxicity tool in treatment-related toxicity in older Chinese patients with cancer. J Geriatr Oncol. 2021;12(4):557–562. doi:10.1016/j.jgo.2020.10.013
   PubMed Web of Science ®Google Scholar
• Ortland I, Mendel Ott M, Kowar M, et al. Comparing the performance of the CARG and the CRASH score for predicting toxicity in older patients with cancer. J Geriatr Oncol. 2020;11(6):997–1005. doi:10.1016/j.jgo.2019.12.016
   PubMed Web of Science ®Google Scholar
• Zhang J, Liao X, Feng J, Yin T, Liang Y. Prospective comparison of the value of CRASH and CARG toxicity scores in predicting chemotherapy toxicity in geriatric oncology. Oncol Lett. 2019;18(5):4947–4955. doi:10.3892/ol.2019.10840
   PubMed Web of Science ®Google Scholar
• Kotzerke D, Moritz F, Mantovani L, et al. The performance of three oncogeriatric screening tools - G8, optimised G8 and CARG - in predicting chemotherapy-related toxicity in older patients with cancer. A prospective clinical study. J Geriatr Oncol. 2019;10(6):937–943. doi:10.1016/j.jgo.2019.04.004
   PubMed Web of Science ®Google Scholar
• Alibhai SM, Aziz S, Manokumar T, Timilshina N, Breunis H. A comparison of the CARG tool, the VES-13, and oncologist judgment in predicting grade 3+ toxicities in men undergoing chemotherapy for metastatic prostate cancer. J Geriatr Oncol. 2017;8(1):31–36. doi:10.1016/j.jgo.2016.09.005
   PubMed Web of Science ®Google Scholar
• Hurria A, Mohile S, Gajra A, et al. Validation of a prediction tool for chemotherapy toxicity in older adults with cancer. J Clin Oncol. 2016;34(20):2366–2371. doi:10.1200/JCO.2015.65.4327
   PubMed Web of Science ®Google Scholar